Functional consequences of sphingomyelinase-induced changes in erythrocyte membrane structure

Cell Death and Disease

Volumn 3, Issue 10, 2012, Pages

  Dinkla, S ^a,b   Wessels, K ^a   Verdurmen, W P R ^a   Tomelleri, C ^c   Cluitmans, J C A ^a   Fransen, J ^a   Fuchs, B ^d   Schiller, J ^d   Joosten, I ^b   Brock, R ^a   Bosman, G J C G M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF VERONA   (Italy)

^d UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Aging; Erythrocyte; Inflammation; Membrane; Sphingomyelinase

Indexed keywords

CERAMIDE; PHOSPHATIDYLSERINE; SPHINGOMYELIN PHOSPHODIESTERASE;

ANEMIA; ARTICLE; BLOOD BANK; BLOOD TRANSFUSION; CELL AGING; CHRONIC INFLAMMATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CRITICALLY ILL PATIENT; CYTOSKELETON; ENZYME ACTIVITY; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE FRAGILITY; ERYTHROCYTE MEMBRANE; ERYTHROCYTE PRESERVATION; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MEMBRANE STRUCTURE; MEMBRANE VESICLE; NORMAL HUMAN; PRIORITY JOURNAL; SPLEEN;

CELL SHAPE; CERAMIDES; CYTOSKELETON; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; HUMANS; MEMBRANE MICRODOMAINS; MICROSCOPY, CONFOCAL; PHOSPHATIDYLSERINES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SPHINGOMYELIN PHOSPHODIESTERASE; TIME FACTORS;

DISCOIDAE;

EID: 84870526451     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2012.143     Document Type: Article

References (44)

1. Bosman GJ, Werre JM, Willekens FL, Novotny VM. Erythrocyte ageing in vivo and in vitro: structural aspects and implications for transfusion. Transfus Med 2008; 18: 335-347.
2. Mohandas N, Gallagher PG. Red cell membrane: past, present, and future. Blood 2008; 112: 3939-3948.
3. Roy CN. Anemia of inflammation. Hematology. Am Soc Hematol Educ Program 2010; 2010: 276-280.
4. Gould S, Cimino MJ, Gerber DR. Packed red blood cell transfusion in the intensive care unit: limitations and consequences. Am J Crit Care 2007; 16: 39-48.
5. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005; 352: 1011-1023.
6. Jenkins RW, Canals D, Hannun YA. Roles and regulation of secretory and lysosomal acid sphingomyelinase. Cell Signal 2009; 21: 836-846.
7. Goni FM, Alonso A. Sphingomyelinases: enzymology and membrane activity. FEBS Lett 2002; 531: 38-46.
8. Grassme H, Riethmuller J, Gulbins E. Biological aspects of ceramide-enriched membrane domains. Prog Lipid Res 2007; 46: 161-170.
9. Hannun YA, Obeid LM. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 2008; 9: 139-150.
10. Lopez-Montero I, Monroy F, Velez M, Devaux PF. Ceramide: from lateral segregation to mechanical stress. Biochim Biophys Acta 2010; 1798: 1348-1356.
11. Hanada K, Mitamura T, Fukasawa M, Magistrado PA, Horii T, Nishijima M. Neutral sphingomyelinase activity dependent on Mg2+ and anionic phospholipids in the intraerythrocytic malaria parasite Plasmodium falciparum. Biochem J 2000; 346(Pt 3): 671-677.
12. D'Alessandro A, Righetti PG, Zolla L. The red blood cell proteome and interactome: an update. J Proteome Res 2010; 9: 144-163.
13. Lang KS, Myssina S, Brand V, Sandu C, Lang PA, Berchtold S et al. Involvement of ceramide in hyperosmotic shock-induced death of erythrocytes. Cell Death Differ 2004; 11: 231-243.
14. Lang F, Gulbins E, Lang PA, Zappulla D, Foller M. Ceramide in suicidal death of erythrocytes. Cell Physiol Biochem 2010; 26: 21-28.
15. Lang F, Lang KS, Lang PA, Huber SM, Wieder T. Osmotic shock-induced suicidal death of erythrocytes. Acta Physiol (Oxf) 2006; 187: 191-198.
16. Kempe DS, Akel A, Lang PA, Hermle T, Biswas R, Muresanu J et al. Suicidal erythrocyte death in sepsis. J Mol Med 2007; 85: 273-281.
17. Lang PA, Schenck M, Nicolay JP, Becker JU, Kempe DS, Lupescu A et al. Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide. Nat Med 2007; 13: 164-170.
18. Hind E, Heugh S, Ansa-Addo EA, Antwi-Baffour S, Lange S, Inal J. Red cell PMVs, plasma membrane-derived vesicles calling out for standards. Biochem Biophys Res Commun 2010; 399: 465-469.
19. Ago H, Oda M, Takahashi M, Tsuge H, Ochi S, Katunuma N et al. Structural basis of the sphingomyelin phosphodiesterase activity in neutral sphingomyelinase from Bacillus cereus. J Biol Chem 2006; 281: 16157-16167.
20. Daleke DL. Phospholipid flippases. J Biol Chem 2007; 282: 821-825.
21. Schiller J, Suss R, Fuchs B, Muller M, Zschornig O, Arnold K. MALDI-TOF MS in lipidomics. Front Biosci 2007; 12: 2568-2579.
22. Fuchs B, Schiller J, Suss R, Schurenberg M, Suckau D. A direct and simple method of coupling matrix-assisted laser desorption and ionization time-of-flight mass spectrometry (MALDI-TOF MS) to thin-layer chromatography (TLC) for the analysis of phospholipids from egg yolk. Anal Bioanal Chem 2007; 389: 827-834.
23. Simons K, Gerl MJ. Revitalizing membrane rafts: new tools and insights. Nat Rev Mol Cell Biol 2010; 11: 688-699.
24. Civenni G, Test ST, Brodbeck U, Butikofer P. In vitro incorporation of GPI-anchored proteins into human erythrocytes and their fate in the membrane. Blood 1998; 91: 1784-1792.
25. Salzer U, R Prohaska. Stomatin, flotillin-1, and flotillin-2 are major integral proteins of erythrocyte lipid rafts. Blood 2001; 97: 1141-1143.
26. van den Akker E, Satchwell TJ, Williamson RC, Toye AM. Band 3 multiprotein complexes in the red cell membrane; of mice and men. Blood Cells Mol Dis 2010; 45: 1-8.
27. Willekens FL, Werre JM, Groenen-Dopp YA, Roerdinkholder-Stoelwinder B, de Pauw B, Bosman GJ. Erythrocyte vesiculation: a self-protective mechanism? Br. J Haematol 2008; 141: 549-556.
28. Bosman GJ, Cluitmans JC, Groenen YA, Werre JM, Willekens FL, Novotny VM. Susceptibility to hyperosmotic stress-induced phosphatidylserine exposure increases during red blood cell storage. Transfusion 2010; 51: 1072-1078.
29. Gevi F, D'Alessandro A, Rinalducci S, Zolla L. Alterations of red blood cell metabolome during cold liquid storage of erythrocyte concentrates in CPD-SAGM. J Proteomics 2012; doi:10.1016/j.jprot.2012.03.012.
30. Bennett-Guerrero E, Veldman TH, Doctor A, Telen MJ, TL Ortel, Reid TS et al. Evolution of adverse changes in stored RBCs. Proc Natl Acad Sci USA 2007; 104: 17063-17068.
31. Kuypers FA, de Jong K. The role of phosphatidylserine in recognition and removal of erythrocytes. Cell Mol Biol (Noisy-le-grand) 2004; 50: 147-158.
32. Montes LR, Lopez DJ, Sot J, Bagatolli LA, Stonehouse MJ, Vasil ML et al. Ceramideenriched membrane domains in red blood cells and the mechanism of sphingomyelinaseinduced hot-cold hemolysis. Biochemistry 2008; 47: 11222-11230.
33. Gauthier E, Guo X, Mohandas N, An X. Phosphorylation-dependent perturbations of the 4.1R-associated multiprotein complex of the erythrocyte membrane. Biochemistry 2011; 50: 4561-4567.
34. An X, Guo X, Sum H, Morrow J, Gratzer W, Mohandas N. Phosphatidylserine binding sites in erythroid spectrin: location and implications for membrane stability. Biochemistry 2004; 43: 310-315.
35. Hagerstrand H, Kralj-Iglic V, Fosnaric M, Bobrowska-Hagerstrand M, Wrobel A, Mrowczynska L et al. Endovesicle formation and membrane perturbation induced by polyoxyethyleneglycolalkylethers in human erythrocytes. Biochim Biophys Acta 2004; 1665: 191-200.
36. Xiong Z, Cavaretta J, Qu L, Stolz DB, Triulzi D, Lee JS. Red blood cell microparticles show altered inflammatory chemokine binding and release ligand upon interaction with platelets. Transfusion 2011; 51: 610-621.
37. Kozuma Y, Sawahata Y, Takei Y, Chiba S, Ninomiya H. Procoagulant properties of microparticles released from red blood cells in paroxysmal nocturnal haemoglobinuria. Br J Haematol 2011; 152: 631-639.
38. Hod EA, Zhang N, Sokol SA, Wojczyk BS, Francis RO, Ansaldi D et al. Transfusion of red blood cells after prolonged storage produces harmful effects that are mediated by iron and inflammation. Blood 2010; 115: 4284-4292.
39. Bosman GJ, Visser FE, de Man AJ, Bartholomeus IG, de Grip WJ. Erythrocyte membrane changes of individuals with Down's syndrome in various stages of Alzheimer-type dementia. Neurobiol Aging 1993; 14: 223-228.
40. Matte A, Low PS, Turrini F, Bertoldi M, Campanella ME, Spano D et al. Peroxiredoxin-2 expression is increased in beta-thalassemic mouse red cells but is displaced from the membrane as a marker of oxidative stress. Free Radic Biol Med 2010; 49: 457-466.
41. Dannenberger D, Suss R, Teuber K, Fuchs B, Nuernberg K, Schiller J. The intact muscle lipid composition of bulls: an investigation by MALDI-TOF MS and 31P NMR. Chem Phys Lipids 2010; 163: 157-164.
42. Fuchs B, Schober C, Richter G, Suss R, Schiller J. MALDI-TOF MS of phosphatidylethanolamines: different adducts cause different post source decay (PSD) fragment ion spectra. J Biochem Biophys Methods 2007; 70: 689-692.
43. Fuchs B, Suss R, Schiller J. An update of MALDI-TOF mass spectrometry in lipid research. Prog Lipid Res 2010; 49: 450-475.
44. Deplaine G, Safeukui I, Jeddi F, Lacoste F, Brousse V, Perrot S et al. The sensing of poorly deformable red blood cells by the human spleen can be mimicked in vitro. Blood 2011; 117: e88-e95.